A clinician’s guide to pediatric and adolescent alopecia areata treatments

The document serves as a comprehensive guide for clinicians treating pediatric and adolescent alopecia areata (AA), emphasizing the importance of shared decision-making and patient-centered communication. It recommends topical corticosteroids as the initial treatment due to their safety and ease of use, while also discussing other treatments like topical minoxidil, intralesional corticosteroids, and JAK inhibitors, which have varying effectiveness and side effects. The guide highlights the psychosocial impact of AA on children and the need for a multidisciplinary approach, including support groups and psychological counseling. It also reviews various treatment options, such as dupilumab, systemic corticosteroids, and phototherapy, stressing the need for individualized treatment plans due to the heterogeneous nature of AA. The document calls for further research to better understand the efficacy and safety of these treatments, particularly in pediatric populations, and notes the limitations of some data sources, which may affect the generalizability of findings.